alosetron Index

Featured: alosetron, Lotronex Main Article

Alosetron (Lotronex) is a drug prescribed for the treatment of severe-predominant IBS among women who suffer from chronic IBS symptoms lasting longer than 6 months, and have not responded to conventional IBS treatment. Side effects, drug interactions, dosage, and pregnancy safety information should be reviewed prior to taking this drug.


    Related Diseases & Conditions

    • Irritable Bowel Syndrome (IBS) Irritable bowel syndrome (IBS) is a GI (gastrointestinal disorder) with symptoms of abdominal pain, bloating, increased flatus,...learn more »
      In This Article
      Irritable Bowel Syndrome (IBS) Article
      • Irritable bowel syndrome (IBS) definition
      • What causes irritable bowel syndrome (IBS)?
      • What are the symptoms of irritable bowel syndrome (IBS)?
      • How is the diagnosis of irritable bowel syndrome (IBS) made?
      • What are the treatments for irritable bowel syndrome (IBS)?
      • What medications are used to treat irritable bowel syndrome (IBS)?
      • What about IBS and diet?
      • Is irritable bowel syndrome (IBS) related to small bacterial overgrowth (SIBO)?
      • What is the prognosis for irritable bowel syndrome (IBS)?
    • Irritable Bowel Syndrome Triggers and Prevention Irritable bowel syndrome (IBS) is a functional disease that can affect the quality of those who suffer from this condition....learn more »
      In This Article
      Irritable Bowel Syndrome Triggers and Prevention Article
      • Irritable bowel syndrome (IBS) triggers and prevention introduction
      • Diet triggers for IBS constipation
      • Diet triggers for IBS diarrhea
      • Stress and anxiety triggers for IBS
      • Drugs that can trigger IBS
      • Menstrual triggers for IBS
      • Other triggers for IBS

Related FAQs, Doctor's & Expert's Views

Health News

Health Features

Tools & References

FDA Drug Labels on

Terms related to alosetron:

  • Lotronex


Get the Latest health and medical information delivered direct to your inbox!